Log In
Print
BCIQ
Print
Print this Print this
 

brimonidine tartrate (Mirvaso) (CD07805/47)

  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionTopical gel formulation of Alphagan P, a relatively selective adrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRosacea
Indication DetailsSymptomatic treatment of facial erythema of rosacea in adult patients; Treat moderate to severe erythema in patients with rosacea
Regulatory Designation

U.S. - Undisclosed Review (Treat moderate to severe erythema in patients with rosacea)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today